Activation of transforming growth factor-β1 and early atherosclerosis in systemic lupus erythematosus

被引:32
作者
Jackson, Michelle
Ahmad, Yasmeen
Bruce, Ian N.
Coupes, Beatrice
Brenchley, Paul E. C.
机构
[1] Manchester Royal Infirm, Manchester Inst Nephrol & Transplantat, Renal Res Labs, Manchester M13 9WL, Lancs, England
[2] Univ Manchester, Manchester Royal Infirm, Cent Manchester & Manchester Childrens Univ NHS T, Rheumatism Res Ctr, Manchester M13 9WL, Lancs, England
基金
英国惠康基金;
关键词
D O I
10.1186/ar1951
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The efficiency of activating latent transforming growth factor (TGF)-beta(1) in systemic lupus erythematosus (SLE) may control the balance between inflammation and fibrosis, modulating the disease phenotype. To test this hypothesis we studied the ability to activate TGF-beta(1) in SLE patients and control individuals within the context of inflammatory disease activity, cumulative organ damage and early atherosclerosis. An Activation Index ( AI) for TGF-beta(1) was determined for 32 patients with SLE and 33 age-matched and sex-matched control individuals by quantifying the increase in active TGF-beta(1) under controlled standard conditions. Apoptosis in peripheral blood mononuclear cells was determined by fluorescence-activated cell sorting. Carotid artery intima-media thickness was measured using standard Doppler ultrasound. These measures were compared between patients and control individuals. In an analysis conducted in patients, we assessed the associations of these measures with SLE phenotype, including early atherosclerosis. Both intima-media thickness and TGF-beta(1) AI for SLE patients were within the normal range. There was a significant inverse association between TGF-beta(1) AI and levels of apoptosis in peripheral blood mononuclear cells after 24 hours in culture for both SLE patients and control individuals. Only in SLE patients was there a significant negative correlation between TGF-beta(1) AI and low-density lipoprotein cholesterol ( r = - 0.404; P = 0.022) and between TGF-beta(1) AI and carotid artery intima-media thickness ( r = - 0.587; P = 0.0004). A low AI was associated with irreversible damage (SLICC [ Systemic Lupus International Collaborating Clinics] Damage Index = 1) and was inversely correlated with disease duration. Intima-media thickness was significantly linked to total cholesterol ( r = 0.371; P = 0.037). To conclude, in SLE low normal TGF-beta(1) activation was linked with increased lymphocyte apoptosis, irreversible organ damage, disease duration, calculated low-density lipoprotein levels and increased carotid IMT, and may contribute to the development of early atherosclerosis.
引用
收藏
页数:7
相关论文
共 32 条
[1]   DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].
BOMBARDIER, C ;
GLADMAN, DD ;
UROWITZ, MB ;
CARON, D ;
CHANG, CH .
ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640
[2]   Cardiovascular disease in lupus patients: Should all patients be treated with statins and aspirin? [J].
Bruce, IN .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2005, 19 (05) :823-838
[3]   Premature atherosclerosis in systemic lupus erythematosus [J].
Bruce, IN ;
Gladman, DD ;
Urowitz, MB .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2000, 26 (02) :257-+
[4]   TRANSFORMING GROWTH-FACTOR BETA(1) IN RENAL-ALLOGRAFT RECIPIENTS [J].
COUPES, BM ;
NEWSTEAD, CG ;
SHORT, CD ;
BRENCHLEY, PEC .
TRANSPLANTATION, 1994, 57 (12) :1727-1731
[5]   Plasma transforming growth factor β1 and platelet activation:: implications for studies in transplant recipients [J].
Coupes, BM ;
Williams, S ;
Roberts, ISD ;
Short, CD ;
Brenchley, PEC .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (02) :361-367
[6]  
DANG H, 1995, J IMMUNOL, V155, P3205
[7]  
EMLEN W, 1994, J IMMUNOL, V152, P3685
[8]  
Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO
[9]  
2-I
[10]   TRANSFORMING GROWTH FACTOR-BETA(1) (TGF-BETA(1) CONTROLS EXPRESSION OF MAJOR HISTOCOMPATIBILITY GENES IN THE POSTNATAL MOUSE - ABERRANT HISTOCOMPATIBILITY ANTIGEN EXPRESSION IN THE PATHOGENESIS OF THE TGF-BETA(1) NULL MOUSE PHENOTYPE [J].
GEISER, AG ;
LETTERIO, JJ ;
KULKARNI, AB ;
KARLSSON, S ;
ROBERTS, AB ;
SPORN, MB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) :9944-9948